The key opinion leader comments on management approaches, while considering patients’ wishes and choosing 1 of the 3 frontline treatment options in follicular lymphoma, including observation, single-agent rituximab, and chemoimmunotherapy.
For more resources and information regarding anticancer targeted therapies: targetedonc.com/
21 окт 2019
